tiprankstipranks
Danaher Corp. (MX:DHR)
:DHR
Mexico Market

Danaher (DHR) Blogger Opinions & Sentiment

0 Followers

Blogger Sentiment

Bullish: 83.33%
Sector Average
Bullish
MX:DHR Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% SeekingAlpha
16% GuruFocus
16% Zacks
18% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Danaher (DHR) Reports Strong Q2 Earnings, Raises Full Year Guidance
GuruFocus
Danaher DHR Q2 Earnings and Revenues Top Estimates
Zacks
Danaher: A Great Way To Play Healthcare For Long-Term Dividend Growth Investors
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of MX:DHR?
Seeking Alpha’s Narek Hovhannisyan has a Neutral Sentiment.
    What do Motley Fool contributors think of MX:DHR?
    Currently there's no blogger sentiment for MX:DHR.
    What Is MX:DHR’s Blogger Sentiment?
    MX:DHR’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for MX:DHR?
      The most recent blogger prediction for MX:DHR was made by GuruFocus News, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          TEMTempus AI, Inc. Class A
          IMMXImmix Biopharma
          PMCUFPro Medicus Limited
          HELPHelus Pharma
          CLVLFClinuvel Pharmaceuticals